+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Interactions of the 5 ht 1 antagonists quipazine spiperone and mesulergine at the serotonin 5 ht nerve terminal autoreceptor in the rat spinal cord



Interactions of the 5 ht 1 antagonists quipazine spiperone and mesulergine at the serotonin 5 ht nerve terminal autoreceptor in the rat spinal cord



Society for Neuroscience Abstracts 13(1): 345




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 028560636

Download citation: RISBibTeXText


Related references

Interactions of substance P antagonists with serotonin in the mouse spinal cord. Peptides 9(4): 909-913, 1988

The serotonin autoreceptor: antagonism by quipazine. Neuropharmacology 21(5): 445-450, 1982

Nerve terminal autoreceptor regulation of serotonin release. Society for Neuroscience Abstracts 15(1): 553, 1989

A pharmacological analysis of the rat spinal cord serotonin (5-HT) autoreceptor. European Journal of Pharmacology 145(2): 163-171, 1988

Failure of supramaximal electrical stimulation of the drn to overcome nerve terminal serotonin autoreceptor activation. Society for Neuroscience Abstracts 13(2): 799, 1987

Serotonin 5-HT-1A autoreceptor blockade potentiates the ability of the 5-HT reuptake inhibitor citalopram to increase nerve terminal output of 5-HT in vivo: A microdialysis study. Journal of Neurochemistry 60(2): 776-779, 1993

Electrophysiological assessment of the effect of the serotonin antagonists methiothepin levo propranolol and tr 2515 on the somatodendritic serotonin autoreceptor. Society for Neuroscience Abstracts 12(1): 575, 1986

The structure of nerve elements in the brain and spinal cord of rabbits following hypothermia, visualized with the light microscope. II. Morphology of nerve cells in the spinal cord, nerve fibres in the spinal cord and brain. Bratislavske Lekarske Listy 66(5): 541-549, 1976

Effects of the serotonin agonist, quipazine, on luteinizing hormone and prolactin release: evidence for serotonin-catecholamine interactions. Life Sciences 35(14): 1481-1487, 1984

Ketanserin and spiperone as templates for novel serotonin 5-HT(2A) antagonists. Current Topics in Medicinal Chemistry 2(6): 539-558, 2002

Serotonin releases adenosine from primary afferent nerve terminals in the spinal cord possible involvement in spinal antinociception. Society for Neuroscience Abstracts 14(2): 852, 1988

Apropos of the Role of Serotonin and some of its Antagonists in Synaptic Processes of the Spinal Cord. Trudy - Institut Normal'noi i Patologicheskoi Fiziologii 117: 84-85, 1964

Ketanserin and Spiperone as Templates for Novel Serotonin 5-Ht2A Antagonists. Current Topics in Medicinal Chemistry 2(6): 539-558, 2002

Serotonin type 2 antagonists inhibit lordosis behavior in the female rat: reversal with quipazine. Life Sciences 38(1): 33-39, 1986

Serotonin type 2 antagonists inhibit lordosis behavior in the female rat reversal with quipazine. Life Sciences 38(1): 33-40, 1985